X

The First Lab-Grown Blood Transfusion

By: John Ortiz, PharmD Candidate c/o 2025 What is a Blood Transfusion? A blood transfusion is a procedure where donated…

eMAR

Pharmacy Benefit Managers 2023 Update

By: Giavanna Carr, PharmD Candidate c/o 2025 In March of 2023, Senators Maria Cantwell and Charles E. Grassley successfully passed…

eMAR

FDA Approves Bimzelx® for the Treatment of Moderate to Severe Plaque Psoriasis

By: Bhojranie Brahmanand, PharmD Candidate c/o 2025 On October 18, 2023, the United States Food and Drug Administration (FDA) approved…

eMAR

The “Morning-After” Antibiotic

By: Anureet Kaur, PharmD Candidate c/o 2024  According to surveillance data from the United States Centers for Disease Control and…

eMAR

6th Year Perspective: From Pharmacy Student to Pfizer Fellow

Featuring: Frances Alexis Dela Cruz, PharmD Candidate c/o 2024 By: Celestine Van Sertima, PharmD Candidate c/o 2027 Frances Alexis Dela…

eMAR

An Oral Revolution in Treating Adults Diagnosed with Type II Diabetes Mellitus

By: Samia Rahman Adity, PharmD Candidate c/o 2025 Diabetes Facts and Statistics Type II diabetes (T2D) has been a consequential…

eMAR

FDA Approves Jardiance® for the Treatment of Adults with Chronic Kidney Disease

By: Urooj K. Malik, PharmD Candidate c/o 2024 Effective September 22, 2023, the United States (U.S.) Food and Drug Administration…

eMAR

Rho Chi Talks: Interview with the CEO of Cullinan Oncology

Featuring: Nadim Ahmed, President and CEO, Cullinan Oncology By: Sairah Skeikh, PharmD Candidate c/o 2024 Nadim Ahmed is the President…

eMAR

From Pharmacy Student to Pharmacist: A Breakdown of Expenses

By: Carolina Vargas, PharmD Candidate c/o 2024, Zoha Khalid, PharmD Candidate c/o 2024, and Nashfa Zaman, PharmD Candidate c/o 2024…

eMAR

The New “Zombie Drug”

By: Sandra Jojo, PharmD Canddiate c/o 2024 The United States (US) is in the midst of an opioid overdose epidemic.…

eMAR